Xometry (NASDAQ:XMTR) ranks ninth on Wall Street's recent list of 10 best all-time high stocks to buy. Analysts project 8 percent average upside potential for the custom manufacturing platform.
The company reported 40 percent revenue growth for two consecutive quarters and posted profit in Q3 with record revenue, driven primarily by its marketplace segment. Chief Financial Officer James Miln confirmed the company maintained 40 percent sales growth for a second straight quarter. The marketplace connects buyers posting designs for custom parts with manufacturers.
Xometry's strength contrasts sharply with a broader rotation out of technology and chipmakers. Over the past month, investors shifted capital into healthcare, financials, real estate, utilities, and consumer stocks.
The shift was stark. By mid-October, healthcare hit a record high among the S&P 500's 11 sectors. Financials rose 1 percent, real estate climbed 1.7 percent, and utilities added 1.2 percent. Technology slipped 0.3 percent. The S&P 500 value index gained 0.9 percent while its growth counterpart dipped 0.2 percent.
Jim Baird, chief investment officer at Plante Moran Financial Advisors, attributed the rotation to growing skepticism about artificial intelligence investment returns. "Investors are looking for other opportunities outside of tech, and healthcare is one of the beneficiaries of that," Baird said. In November, money accelerated toward companies with stable, predictable earnings.
The selling intensified. On last Monday, investors rotated into consumer cyclical, financial services, and consumer defensive stocks. The technology sector fund dropped 2.4 percent by mid-afternoon. The Philadelphia Semiconductor Index fell 11 percent last Thursday, its worst performance since March 2020.
The Nasdaq Composite entered a correction, dropping at least 10 percent from its early October record close. The VIX jumped more than 65 percent in a single day, reflecting rapid capital reallocation.
Sameer Samana, senior global market strategist at Wells Fargo Investment Institute, pointed to the concentrated nature of the selloff. "Anything related to AI is down more than anything not related to AI," Samana said. A new cohort of buyers has emerged, prioritizing companies with healthy cash flow over pure growth as many AI stocks remain expensive.
Will Compernolle, macro strategist at FHN Financial, observed that selling pressure on chipmakers directed funds into Treasuries. Investors also rotated from chipmakers into the largest spenders on AI data centers, signaling selective positioning within AI-related plays.
Charlie McElligott, cross-asset strategist at Nomura, offered a different interpretation: the selloff reflected hedge funds locking in 2026 gains rather than a deterioration in fundamental market conditions.
